DayTwo, a leader in microbiome-health management, announced it has completed a $12.0 million Series A round of financing through Johnson & Johnson Innovation – JJDC, Inc. (JJDC), Seventure Partners’ Health for Life Capital fund, Mayo Clinic, co-founder Marius Nacht, and other private investors.

Strategic Interests has been integral in helping DayTwo create strategy and business plans, connect to their first US research partner, developed Segment-Specific Market Attack Plan (S2MAP), and we are helping to launch the business in the US. We are fortunate to have the opportunity to work with such a talented team, and thrilled to know we helped them reach this significant milestone.

Link: DayTwo Secures $12M Series A Financing Round